aldicarb has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arantes, LP; Golombieski, R; Machado, ML; Soares, FA; Zamberlan, DC | 1 |
| Arya, U; Das, CK; Dwivedi, H; Gupta, K; Kumar, R; Saharia, K; Sahu, R; Subramaniam, JR | 1 |
2 other study(ies) available for aldicarb and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Diphenyl-diselenide suppresses amyloid-β peptide in Caenorhabditis elegans model of Alzheimer's disease.
Topics: Aldicarb; Alzheimer Disease; Amyloid beta-Peptides; Animals; Animals, Genetically Modified; Antioxidants; Association Learning; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Cholinesterase Inhibitors; Disease Models, Animal; Heat-Shock Proteins; Motor Activity; Organoselenium Compounds; Oxidative Stress; Peptide Fragments | 2014 |
Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent Aβ proteotoxicity in Caenorhabditis elegans.
Topics: Acetylcholine; Aging; Aldicarb; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antihypertensive Agents; Caenorhabditis elegans; Cholinesterase Inhibitors; Longevity; Neurotransmitter Agents; Reserpine; Vesicular Monoamine Transport Proteins | 2012 |